TNGX
Tango Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$23.53
+6.76%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 864.97x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.87x
- Price / sales
- 73.73x
- Price / cash flow
- -27.57x
Enterprise value
- Enterprise value
- $3.0B
- EV / sales
- 55.48x
- EV / EBITDA
- -24.50x
- EV / EBIT
- -21.90x
- Market cap
- $4.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026